CEDAR KNOLLS, N.J. – Fingerpaint, a full-service marketing agency with offices in New York, Pennsylvania, Arizona, and New Jersey, has added Gina Marrone, Ph.D., to its medical strategy team. Marrone will be based in the agency’s Cedar Knolls, N.J., office.
Marrone, an award-winning medical scholar, joins Fingerpaint from Havas Tonic, where she was a medical researcher. She did post-doctoral work at the Rutgers Brain Health Institute and graduate work at Memorial Sloan Kettering Cancer Center. In addition, Marrone has published 20 papers and presented on a range of topics in neuropharmacology, addiction, and pain. She has been a medical lead in multiple categories, including neurology, cardiology, and diabetes.
Marrone earned her doctorate degree in Neuroscience from the Weill Cornell Graduate School of Medical Sciences.
“Gina has made an immediate impact on our business at Fingerpaint,” said Nick Megjugorac, who leads strategy at Fingerpaint’s Cedar Knolls office. “She’s intelligent, perceptive, and able to translate the most complex information into meaningful communication.”
Reset your expectations of a marketing agency. Independent by design, with integrated talent across Saratoga Springs, New York; Conshohocken, Pennsylvania; Phoenix, Arizona; and Cedar Knolls, New Jersey, Fingerpaint is committed to creating and executing meaningful brand experiences that are never paint by number.
Fingerpaint was named 2019 Agency of the Year by Med Ad News. It was a 2017 finalist for Agency of the Year by Med Ad News, MM&M, and PM360 and won PR & Marketing Agency of the Year in 2017 from the Business Intelligence Group. Additionally, it won the 2018 Heart Award from Med Ad News for its commitment to philanthropy and social causes and has been on Inc. Magazine’s list of the 5,000 Fastest-Growing Companies for the past seven years. Founder Ed Mitzen was honored as 2016’s Industry Person of the Year by Med Ad News and as a 2017 Top Boss by Digiday. Visit us at fingerpaint.com and follow us on Facebook, Twitter, LinkedIn, and Instagram.